Alnylam Pharmaceuticals Inc. (ALNY) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Alnylam Pharmaceuticals I...

    NASDAQ: ALNY · Real-Time Price · USD
    455.03
    3.03 (0.67%)
    At close: Sep 08, 2025, 3:59 PM
    457.05
    0.44%
    After-hours: Sep 08, 2025, 07:52 PM EDT

    Alnylam Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -278.16M -440.24M -1.13B -852.82M
    Depreciation & Amortization
    		 56.67M 97.03M 85.55M 89.69M
    Stock-Based Compensation
    		 272.08M 221.68M 230.65M 165.72M
    Other Working Capital
    		 -232.22M -509K -147.59M -122.85M
    Other Non-Cash Items
    		 261.94M 214.93M 309.24M 174.24M
    Deferred Income Tax
    		 -106.76M n/a n/a -55.7M
    Change in Working Capital
    		 -214.08M 10.76M -35.55M -162.82M
    Operating Cash Flow
    		 -8.31M 104.16M -541.27M -641.69M
    Capital Expenditures
    		 -34.28M -62.21M -72.06M -76.37M
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -1.71B -1.82B -1.98B -1.66B
    Sales Maturities Of Investments
    		 1.57B 1.55B 2.23B 1.46B
    Other Investing Acitivies
    		 57.76M -4.44M -13.19M -4.36M
    Investing Cash Flow
    		 -116.84M -336.35M 169.35M -273.3M
    Debt Repayment
    		 n/a n/a 254M 500M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -8.79M 24.67M -87.61M 500.85M
    Financial Cash Flow
    		 294.16M 172.13M 425.75M 1.25B
    Net Cash Flow
    		 153.77M -53.67M 46.4M 323.11M
    Free Cash Flow
    		 -42.59M 41.95M -613.33M -718.07M

    Add to Watchlist